Navigation Links
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Date:5/29/2009

the study includes patients being administered neratinib (160 mg or 240 mg) daily plus weekly trastuzumab (4 mg/kg IV loading dose then 2 mg/kg). In the second part of the study, patients receive a weekly dose of trastuzumab with daily neratinib (240 mg).

To date, 45 patients have been enrolled and 28 patients were evaluable for efficacy. The 16-week PFS rate (for part 2) was 45 percent (95 percent CI, 26 percent to 62 percent); median PFS was 16 weeks (95 percent CI, 15 to 31 weeks). The complete response rate was 7 percent, while 21 percent of evaluable patients showed partial response. The objective response rate was 29 percent (95 percent CI, 13 percent to 49 percent).

In this study, adverse events of any grade were diarrhea, nausea, anorexia, vomiting, asthenia, rash and fatigue. In the 45 patients enrolled in this study, diarrhea was the most common adverse event, observed in 91 percent of patients, and was the most significant grade 3 or 4 adverse event, occurring in 16 percent of patients. Two patients receiving neratinib 240 mg reported adverse events leading to discontinuation of therapy.

Safety and Efficacy of Neratinib (HKI-272) in Combination with Paclitaxel in Patients with Solid Tumors

In a separate phase 1/2, open-label, 2-part study, ascending multiple daily oral doses of neratinib (160 mg, 240 mg) were administered in combination with IV paclitaxel 80 mg/m2, if tolerable, or 70 mg/m2 on days 1, 8 and 15. Patients with solid tumors (endometrial, cervical, colorectal and esophageal cancers) were entered in the phase 1 portion (part 1), and only patients with metastatic ErbB-2 positive breast cancer were enrolled in part 2. Safety and efficacy were investigated in patients with ErbB-2 positive metastatic breast cancer.

A total of 102 patients were enrolled in part 2 of the study and 97 patients were evaluable for efficacy. The overall
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
2. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
3. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
4. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
5. Genaera Presents Preliminary Phase 1b Data for Trodusquemine (MSI-1436)
6. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
7. Neuronetrix Announces Preliminary Alzheimers Study Results at the Society for Neuroscience Conference
8. CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
9. Preliminary Data From Experimental Study Demonstrate Increased Mortality in Stroke Patients Treated With Epoetin Alfa
10. What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study
11. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Reportlinker.com announces that a new market ... Portugal Pharmaceuticals and Healthcare Report Q3 ... Includes 3 FREE quarterly updates ... last quarter has led us to revise our ... previously, BMI expects Portugal,s ...
(Date:7/28/2014)...  UBM Medica US announces that Diagnostic ... imaging professionals, explored the complex situation regarding measuring ... The shift from fee-for-service has left radiology at ... is determined in the new payment model . ... field, who recognized the complexity of the radiologist,s value: ...
(Date:7/28/2014)... 2014  MedSpring Urgent Care, an Austin -based ... Lamar Blvd., Austin, TX 78704 on Saturday, ... the southeast corner of Barton Springs Rd. and S. ... 9 p.m. daily, including weekends and holidays. With existing ... Austin , Anderson Mill , Cedar Park ...
Breaking Medicine Technology:Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Diagnostic Imaging Delves into Measuring the Radiologist's Value 2MedSpring Urgent Care opens Barton Springs walk-in clinic in Austin, TX 2
... PARSIPPANY, N.J., Sept. 22, 2011 Watson Pharmaceuticals, Inc. ... Pharmaceuticals, Inc. and Sandoz Inc. have filed suit against ... in the United States District Court for the District ... Injection product, which Watson has the exclusive right to ...
... Sept. 22, 2011 Sanovas Inc. , a ... and treatment of pulmonary disease and lung cancer, today ... at AdvaMed 2011, the industry,s premier medical technology conference ... Gerrans, an industry veteran, will be participating in an ...
Cached Medicine Technology:Watson Confirms Amphastar Patent Lawsuit 2Watson Confirms Amphastar Patent Lawsuit 3Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011 2
(Date:7/28/2014)... (PRWEB) July 28, 2014 Shofner ... Operation Military June . Renowned LASIK and Cataract ... to provide significant funds and public awareness for ... retired military personnel and their families. “This was ... proudly give nearly $5,000 to a variety of ...
(Date:7/28/2014)... more chronic medical conditions people have at retirement age, ... study claims. Since nearly four in five ... Hopkins Bloomberg School of Public Health in Baltimore said ... expectancy are slowing in the United States. "Living ... and heart failure is now the norm and not ...
(Date:7/28/2014)... SIMpalm helped its client to ... available on iTunes for download . Experience a new ... allows you to listen and cook along with expert real-time ... get out the ingredients and equipment, press play, and follow ... ingredients ahead of time, just relax and cook along with ...
(Date:7/28/2014)... 2014 Bariatric Eating, a leading supplier ... it will be introducing three additional flavors to its ... The additional flavors include: , Inspire Summer Melon - ... Inspire Pomegranate Razz Berry -­ Pomegranate, razz and other ... cone , Bariatric Eating's Inspire protein powders ...
(Date:7/28/2014)... 2014 Lourdes Health System has partnered ... reduced wait times for veterans needing medical care. , ... the state—and the only one in Camden, Burlington and ... Care program (PC3). PC3 gives veterans access to specialty ... provide services due to lack of available specialists, long ...
Breaking Medicine News(10 mins):Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2Health News:Lourdes Expands Military Partnership with Veterans 2Health News:Lourdes Expands Military Partnership with Veterans 3
... External Affairs Minister Pranab Mukherjee was discharged from the Army ... a road accident in West Bengal. , ... morning and was satisfied with his fast pace of recovery. ... Mukherjee, including CT (computed omography) and MRI (magnetic resonance imaging) ...
... day temperatures in state capital Raipur and the northern ... degrees Celsius. ,Roads wore a deserted look ... preferred to remain indoors while government offices recorded thin ... further rise in heat this week with daytime temperatures ...
... - The Food and Drug Administration has warned that ... children and adults// could also cause side effects like ... clear warnings on the drug, the FDA has indicated ... public. The FDA intends to modify the precautions on ...
... pharmaceutical multi-national, the Abbott, has agreed to lower the ... to one thousand// US dollars, on a request from ... ,Kaletra is indicated for the treatment of HIV-1 ... years, in combination with other antiretroviral agents. It is ...
... analysis of a previously published research in the April ... that foods rich in cocoa are beneficial// in reducing ... help. ,Current guidelines advise individuals with hypertension ... according to background information in the article. Compounds known ...
... stressed. Who wouldn’t be with a daughter like Tracey! But ... her way through// a mountain of cigarettes three or four ... formerly Langton and Rachid) is a long-running character on the ... Anne Kirkbride since 1972. Deirdre has become synonymous with a ...
Cached Medicine News:Health News:Abbott to Subsidize Price of HIV Drug 2Health News:Blood Pressure Tackled Better With Cocoa Than Tea 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 2Health News:Smoking on Television is Harmful to the Health of the Nation's Youth: BMA 3
Inquire...
... non-contact diagnostic lens, doctors have to make a ... high magnification. Now, with the Digital Wide ... can have both in one lens. This ... in a non-contact lens paired with the higher ...
... portability & capability together in this user-friendly, ... desktop maginifcation., ,With its battery powered option, ... meet any individual, education or business environment ... a briefcase from room to room or ...
... can have accurate patient information and secure dictation ... track of patient schedules, manage daily workflow and ... PC handheld device. PhysAssist IQ is a handheld ... does not require physicians to change the way ...
Medicine Products: